Inotek Pharma (ITEK) to Merge with Rocket Pharmaceuticals Sep 12, 2017 04:16PM
Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare Diseases Sep 12, 2017 04:15PM
Vasuda Capital Management Seeks to Inspects Books and Records of Inotek Pharmaceuticals (ITEK) Related to Potential Sale Aug 31, 2017 06:12AM
Inotek Pharmaceuticals Corporation Reports Second Quarter 2017 Financial Results and Operational Highlights Aug 3, 2017 04:01PM
Inotek Pharma (ITEK) Phase 2 Results of Trabodenoson Showed No Meaningful Clinical Advantage at Day 56 Jul 7, 2017 04:02PM


Jul 7, 2017 04:01PM Inotek Pharmaceuticals Announces Top-line Results of Phase 2 Fixed-dose Combination Trial of Trabodenoson and Provides Corporate Update
Aug 2, 2016 07:01AM Inotek Pharmaceuticals Announces Pricing of $50.0 Million of 5.75% Convertible Senior Notes due 2021
Aug 1, 2016 07:01AM Inotek Pharmaceuticals Announces Proposed Public Offering of $50 Million of Convertible Senior Notes due 2021